Conleth Anthony Egan

The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease.

K. Yancey, C. Egan, Kim B. Yancey, 2000, European journal of dermatology : EJD.

Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis.

J. Saffle, J. Zone, S. Morris, 1999, Journal of the American Academy of Dermatology.

Benign symmetric lipomatosis in a Chinese man with bullous pemphigoid

M. H. Ho, K. Lo, T. Rallis, 1999, International journal of dermatology.

The Immunoglobulin A Antibody Response in Clinical Subsets of Mucous Membrane Pemphigoid

J. Zone, L. Meyer, M. Petersen, 1999, Dermatology.

Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx.

G. Krueger, K. Meadows, C. Egan, 1999, Journal of the American Academy of Dermatology.

Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations.

K. Yancey, C. Egan, Kim B. Yancey, 2000, JAMA.

Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.

M. Brown, K. Yancey, J. D. White, 2001, Clinical immunology.